Oramed Pharmaceuticals Inc. (TLV:ORMP)

Oramed Pharmaceuticals Statistics

Total Valuation

TLV:ORMP has a market cap or net worth of ILS 428.17 million. The enterprise value is 10.34 million.

Market Cap	428.17M
Enterprise Value	10.34M

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	Jan 16, 2026

Share Statistics

Current Share Class	39.80M
Shares Outstanding	n/a
Shares Change (YoY)	+3.29%
Shares Change (QoQ)	+0.39%
Owned by Insiders (%)	15.86%
Owned by Institutions (%)	15.72%
Float	30.32M

Valuation Ratios

The trailing PE ratio is 2.95.

PE Ratio	2.95
Forward PE	n/a
PS Ratio	64.66
PB Ratio	0.64
P/TBV Ratio	0.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.07
EV / Sales	1.67
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.29

Financial Position

The company has a current ratio of 22.24, with a Debt / Equity ratio of 0.00.

Current Ratio	22.24
Quick Ratio	22.08
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.08
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 24.48% and return on invested capital (ROIC) is -16.35%.

Return on Equity (ROE)	24.48%
Return on Assets (ROA)	-4.22%
Return on Invested Capital (ROIC)	-16.35%
Return on Capital Employed (ROCE)	-6.07%
Weighted Average Cost of Capital (WACC)	10.71%
Revenue Per Employee	1.66M
Profits Per Employee	36.30M
Employee Count	4
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, TLV:ORMP has paid 39.52 million in taxes.

Income Tax	39.52M
Effective Tax Rate	21.41%

Stock Price Statistics

The stock price has increased by +35.58% in the last 52 weeks. The beta is 1.19, so TLV:ORMP's price volatility has been higher than the market average.

Beta (5Y)	1.19
52-Week Price Change	+35.58%
50-Day Moving Average	975.69
200-Day Moving Average	813.88
Relative Strength Index (RSI)	52.87
Average Volume (20 Days)	17,857

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.68

Income Statement

In the last 12 months, TLV:ORMP had revenue of ILS 6.62 million and earned 145.20 million in profits. Earnings per share was 3.40.

Revenue	6.62M
Gross Profit	43,044
Operating Income	-43.08M
Pretax Income	184.57M
Net Income	145.20M
EBITDA	-42.68M
EBIT	-43.08M
Earnings Per Share (EPS)	3.40

Balance Sheet

The company has 445.96 million in cash and 2.85 million in debt, with a net cash position of 443.11 million.

Cash & Cash Equivalents	445.96M
Total Debt	2.85M
Net Cash	443.11M
Net Cash Per Share	n/a
Equity (Book Value)	669.93M
Book Value Per Share	16.48
Working Capital	430.44M

Cash Flow

In the last 12 months, operating cash flow was -35.06 million and capital expenditures -59,600, giving a free cash flow of -35.12 million.

Operating Cash Flow	-35.06M
Capital Expenditures	-59,600
Free Cash Flow	-35.12M
FCF Per Share	n/a

Margins

Gross margin is 0.65%, with operating and profit margins of -650.55% and 2,192.60%.

Gross Margin	0.65%
Operating Margin	-650.55%
Pretax Margin	2,787.20%
Profit Margin	2,192.60%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.79, which amounts to a dividend yield of 7.24%.

Dividend Per Share	0.79
Dividend Yield	7.24%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	23.11%
Buyback Yield	-3.29%
Shareholder Yield	4.10%
Earnings Yield	33.91%
FCF Yield	-8.20%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TLV:ORMP has an Altman Z-Score of 2.8 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.8
Piotroski F-Score	1